Search results
EAN 2024: The role of B cells in shaping rituximab use in generalised MG
Clinical Trials Arena· 2 days agoGiven the negative side-effect profiles of the aforementioned therapies and the fact that they do...
CEPI announces plans for Nipah virus antibody trials
Clinical Trials Arena· 2 days agoThe Coalition for Epidemic Preparedness Innovations (CEPI) has announced plans to commence clinical trials to evaluate MBP1F5, a monoclonal antibody (mAb...
Glenmark Pharma. Summary: Latest Updates and Details | India Infoline
India Infoline· 3 days agoGlenmark Pharmaceuticals Ltd Summary: Check out the latest management information and corporate updates of Glenmark Pharma. at India Infoline
Nipah monoclonal antibody to undergo human trials in India, Bangladesh in 2025
IBTmes India· 3 days agoA novel monoclonal antibody against the Nipah virus is set to undergo human clinical trials in...
FDA approves Eli Lilly’s Kisunla (donanemab) for early AD
Pharmaceutical Technology· 3 days agoEli Lilly announced on 2 July 2024 that the US Food and Drug Administration (FDA) has approved its...
Cipla Ltd Management Discussions | India Infoline
India Infoline· 4 days agoCipla Ltd Management Discussions: Check out the latest updates, and news about the Cipla management discussions at India Infoline
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 4 days agoThe deal, which was agreed upon in May this year and includes $650m in milestone payments, sees...
EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging
Clinical Trials Arena· 4 days agoA further key challenge highlighted during the symposium is that due to the variability of migraine...
Emergent scores US medical countermeasure contracts worth over $250m
Pharmaceutical Technology· 4 days agoThe company will supply four products – vaccines for anthrax and smallpox, VIV for treating smallpox...
Johnson & Johnson reports data from Phase III multiple myeloma treatment trial
Clinical Trials Arena· 4 days agoLast month, the company announced findings from the Phase II DAHLIAS dose-ranging study, where its ...